Key result
Study evaluates clinical responses to adenovirus 26 and 27 cross-challenges in conjunctivitis and enteric infection.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Does not support changes in adenovirus management; leaves open optimal serotype coverage for vaccines.
Julius A. Kasel, Hugh E. Evans, Anderson Spickard, Vernon Knight; Conjunctivitis and Enteric Infection With Adenovirus Types 26 and 27: Responses to Primary, Se
No takes yet. Share an insight, caveat, or question.
Kasel et al. (1963) studied this question. Adenovirus types 26 and 27 were evaluated for clinical responses to primary, secondary, and reciprocal cross-challenges in relation to conjunctivitis and enteric infection.
Synapse has enriched 10 related papers. Consider them for comparative context: